We evaluate BCG intratumoral treatment in a subcutaneous MB49 tumor model using different knockout (KO) mice (STING−/−, cGAS−/−, TLR2−/−, TLR3−/−, TLR4−/−, TLR7−/−, TLR9−/−, TLR3/7/9−/−, MyD88−/−, IL-1R−/−, Caspase1/11−/−, Gasdermin-D−/− and IFNAR−/−). This evidence concerns the gene STING1 and neoplasm.